CDH1 and prostate cancer: Expression of miR-23b/-27b increased E-cadherin protein levels in two independent CRPC cell lines; conversely inhibition of miR-23b/-27b in a less aggressive androgen-dependent prostate cancer cell line, LNCaP, resulted in a decrease of E-cadherin levels.